Vincerx Pharma, Inc. Total Liabilities
Vincerx Pharma, Inc. had Total Liabilities of $2.62 million as of 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-05-15
- 2025-03-31: Liabilities $2.62M.
- 2024-12-31: Liabilities $5.28M.
- 2024-09-30: Liabilities $5.84M.
- 2024-06-30: Liabilities $6.08M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-03-31 | $2.62M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $5.28M 10-Q · filed 2025-05-15 | |
| 2024-09-30 | $5.84M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $6.08M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $11.71M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.00M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $10.54M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $11.14M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $12.98M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $11.62M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $12.67M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $13.38M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $14.71M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $17.36M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $28.80M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $19.54M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $32.45M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $37.81M 10-K · filed 2022-03-29 | $5.50M 10-K · filed 2021-03-22 |
| 2020-09-30 | $3.70M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $3.41M 10-Q · filed 2020-11-10 | |
| 2020-03-31 | $3.33M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $44.00K 10-K/A · filed 2021-05-14 | |
| 2019-06-30 | $1.45K 10-K · filed 2020-09-23 |